Abstract
The first series of cell-penetrating penta-peptides (CPP5s) were discovered as cytoprotective penta-peptides designed from the Bax-inhibiting domain of Ku70. Bax is an inducer of programmed cell death, and Ku70 is a multifunctional protein maintaining genomic stability and protecting cells from death by inhibiting the cytotoxic activity of Bax. Since these peptides bind and inhibit Bax, they are named Bax-inhibiting peptides (BIPs). The second series of CPP5s were developed by mutating BIP’s amino acid sequences to abolish the Bax-binding activity. These peptides were used as negative control peptides to evaluate the Bax-inhibiting activity of BIPs. CPP5s are able to enter cells when they are added to the culture medium. The mechanism of cell entry of CPP5s is not yet understood. Numerous studies showed that BIP rescued cells from cytotoxic stresses both in cell culture and animal model, suggesting the therapeutic potential of BIP. Both BIPs and noncytoprotective CPP5s did not show significant toxicity even at 1.6 mM concentration in cell culture. Our recent study suggests that CPP5s has the protein transduction activity, though only green fluorescent protein (GFP) has been tested as a cargo protein. If CPP5s can deliver wide range of cargo molecules into the cell, CPP5s may be utilized as nontoxic drug delivery tool. In this article, we describe our laboratory’s protocols of how to synthesize, store, and apply CPP5s for the examination of their activities of cell penetration and cytoprotection.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Gomez, J. A., Gama, V., Yoshida, T., Sun, W., Hayes, P., Leskov, K., Boothman, D., and Matsuyama, S. (2007) Bax-inhibiting peptides derived from Ku70 and cell-penetrating pentapeptides, Biochem Soc Trans 35, 797–801.
Li, Y., Yokota, T., Gama, V., Yoshida, T., Gomez, J. A., Ishikawa, K., Sasaguri, H., Cohen, H. Y., Sinclair, D. A., Mizusawa, H., and Matsuyama, S. (2007) Bax-inhibiting peptide protects cells from polyglutamine toxicity caused by Ku70 acetylation, Cell Death Differ 14, 2058–2067.
Yoshida, T., Tomioka, I., Nagahara, T., Holyst, T., Sawada, M., Hayes, P., Gama, V., Okuno, M., Chen, Y., Abe, Y., Kanouchi, T., Sasada, H., Wang, D., Yokota, T., Sato, E., and Matsuyama, S. (2004) Bax-inhibiting peptide derived from mouse and rat Ku70, Biochem Biophys Res Commun 321, 961–966.
Doherty, A. J. and Jackson, S. P. (2001) DNA repair: how Ku makes ends meet, Curr Biol 11, R920–R924.
Downs, J. A. and Jackson, S. P. (2004) A means to a DNA end: the many roles of Ku, Nat Rev Mol Cell Biol 5, 367–378.
Pujals, S., Fernandez-Carneado, J., Ludevid, M. D., and Giralt, E. (2008) D-SAP: a new, noncytotoxic, and fully protease resistant cell-penetrating peptide, Chem Med Chem 3, 296–301.
Gomez, J. A., Gama, V., and Matsuyama, S. (2006) Cell-permeable penta-peptides derived from Bax-inhibiting peptide, Cell Penetrating Peptide (Ed. Langel, U.), 2nd edition, pp. 469–481. CRC, Boca Raton.
Chen, Y. N., Yamada, H., Mao, W., Matsuyama, S., Aihara, M., and Araie, M. (2007) Hypoxia-induced retinal ganglion cell death and the neuroprotective effects of beta-adrenergic antagonists, Brain Res 1148, 28–37.
Iriyama, T., Kamei, Y., Kozuma, S., and Taketani, Y. (2009) Bax-inhibiting peptide protects glutamate-induced cerebellar granule cell death by blocking Bax translocation, Neurosci Lett 451, 11–15.
Maeda, A., Maeda, T., Golczak, M., Chou, S., Desai, A., Hoppel, C. L., Matsuyama, S., and Palczewski, K. (2009) Involvement of all-trans-retinal in acute light-induced retinopathy of mice, J Biol Chem 284, 15173–15183.
Yu, L. Y., Jokitalo, E., Sun, Y. F., Mehlen, P., Lindholm, D., Saarma, M., and Arumae, U. (2003) GDNF-deprived sympathetic neurons die via a novel nonmitochondrial pathway, J Cell Biol 163, 987–997.
Tanaka, K., Kobayashi, N., Gutierrez, A. S., Rivas-Carrillo, J. D., Navarro-Alvarez, N., Chen, Y., Narushima, M., Miki, A., Okitsu, T., Noguchi, H., and Tanaka, N. (2006) Prolonged survival of mice with acute liver failure with transplantation of monkey hepatocytes cultured with an antiapoptotic pentapeptide V5, Transplantation 81, 427–437.
Hehl, A. B., Regos, A., Schraner, E., and Schneider, A. (2007) Bax function in the absence of mitochondria in the primitive protozoan Giardia lamblia, PLoS One 2, e488.
Qin, Q., Patil, K., and Sharma, S. C. (2004) The role of Bax-inhibiting peptide in retinal ganglion cell apoptosis after optic nerve transection, Neurosci Lett 372, 17–21.
Wadia, J. S., Stan, R. V., and Dowdy, S. F. (2004) Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis, Nat Med 10, 310–315.
Acknowledgment
This work was supported in part by National Institute of Health (NIH) grants RO1AG031903 (to Shigemi Matsuyama) and PC0CA1037 (Pilot Grant from Case Comprehensive Cancer center), and an American heart Association fellowship 0615139B (to Jose Gomez). The Study was also supported in part by the Flow Cytometry and Confocal Microscopy core facilities of the Comprehensive Cancer Center of Case western Reserve University and University Hospital P30CA43703.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Gomez, J., Matsuyama, S. (2011). Cell-Penetrating Penta-Peptides and Bax-Inhibiting Peptides: Protocol for Their Application. In: Langel, Ü. (eds) Cell-Penetrating Peptides. Methods in Molecular Biology, vol 683. Humana Press. https://doi.org/10.1007/978-1-60761-919-2_33
Download citation
DOI: https://doi.org/10.1007/978-1-60761-919-2_33
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60761-918-5
Online ISBN: 978-1-60761-919-2
eBook Packages: Springer Protocols